Joseph J. Lynch

6.6k total citations
165 papers, 4.3k citations indexed

About

Joseph J. Lynch is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Joseph J. Lynch has authored 165 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Cardiology and Cardiovascular Medicine, 49 papers in Molecular Biology and 25 papers in Hematology. Recurrent topics in Joseph J. Lynch's work include Cardiac electrophysiology and arrhythmias (73 papers), Cardiac Arrhythmias and Treatments (40 papers) and Ion channel regulation and function (27 papers). Joseph J. Lynch is often cited by papers focused on Cardiac electrophysiology and arrhythmias (73 papers), Cardiac Arrhythmias and Treatments (40 papers) and Ion channel regulation and function (27 papers). Joseph J. Lynch collaborates with scholars based in United States, United Kingdom and Japan. Joseph J. Lynch's co-authors include Benedict R. Lucchesi, Audrey A. Wallace, Elizabeth Baskin, Asrar B. Malik, Christopher P. Regan, Joseph J. Salata, Daniel Montgomery, Gary L. Stump, Raymond F. Stupienski and Nancy K. Jurkiewicz and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

Joseph J. Lynch

163 papers receiving 4.1k citations

Peers

Countries citing papers authored by Joseph J. Lynch

Since Specialization

Citations

This map shows the geographic impact of Joseph J. Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph J. Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph J. Lynch more than expected).

Fields of papers citing papers by Joseph J. Lynch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph J. Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph J. Lynch. The network helps show where Joseph J. Lynch may publish in the future.

Co-authorship network of co-authors of Joseph J. Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph J. Lynch. A scholar is included among the top collaborators of Joseph J. Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph J. Lynch. Joseph J. Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early echocardiographic predictors of outcomes in the mouse transverse aortic constriction heart failure model 2016 ·Journal of Pharmacological and Toxicological Methods ·(unknown), Raymond Rosa, Barry J. Campbell, Richard P. Kennan, (unknown), (unknown), Xiaolan Shen, Kersten M. Small, Jeffrey B. Madwed, Joseph J. Lynch	11
2	The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation 2013 ·Cardiovascular Research ·Erich Wettwer, Torsten Christ, (unknown), (unknown), Klaus Matschke, Joseph J. Lynch, Marc Pourrier, John K. Gibson, David Fedida, Michael Knaut, Ursula Ravens	81
3	P3 optimization of functional potency, in vivo efficacy and oral bioavailability in 3-aminopyrazinone thrombin inhibitors bearing non-charged groups at the P1 position 2010 ·Bioorganic & Medicinal Chemistry Letters ·Richard C.A. Isaacs, (unknown), (unknown), Swati P. Mercer, Bruce D. Dorsey, Colleen M. McDonough, Jacquelynn J. Cook, Julie A. Krueger, Sidney D. Lewis, Bobby J. Lucas, Elizabeth A. Lyle, Joseph J. Lynch, Cynthia Miller‐Stein, (unknown), Audrey A. Wallace, Rebecca B. White, Bradley K. Wong	3
4	Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel 2010 ·Bioorganic & Medicinal Chemistry Letters ·Douglas C. Beshore, Nigel J. Liverton, Charles McIntyre, Christopher F. Claiborne, Brian E. Libby, Joseph Culberson, Joseph J. Salata, Christopher P. Regan, Joseph J. Lynch, László Kiss, Robert H. Spencer, (unknown), Rebecca B. White, Suzie Yeh, George D. Hartman, Christopher J. Dinsmore	12
5	Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Richard C.A. Isaacs, (unknown), (unknown), Swati P. Mercer, Linda S. Payne, Kenneth J. Stauffer, Peter Williams, Jacquelynn J. Cook, Julie A. Krueger, Sidney D. Lewis, Bobby J. Lucas, Elizabeth A. Lyle, Joseph J. Lynch, Daniel R. McMasters, Adel M. Naylor-Olsen, (unknown), Audrey A. Wallace	6
6	Hemodynamic and Cardiac Neurotransmitter-releasing Effects in Conscious Dogs of Attention- and Wake-promoting Agents: A Comparison of d-Amphetamine, Atomoxetine, Modafinil, and a Novel Quinazolinone H3 Inverse Agonist 2009 ·Journal of Cardiovascular Pharmacology ·Joseph J. Lynch, Christopher P. Regan, Gary L. Stump, Pamela L. Tannenbaum, Joanne Stevens, Ashleigh Bone, (unknown), (unknown), (unknown), Norihiro Takenaga, Shigeru Tokita, Tsuyoshi Nagase, Nagaaki Sato, John J. Renger	8
7	Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles 2008 ·Bioorganic & Medicinal Chemistry Letters ·Richard C.A. Isaacs, (unknown), (unknown), (unknown), Adel M. Naylor-Olsen, Daniel R. McMasters, Julie A. Krueger, Sidney D. Lewis, Bobby J. Lucas, Lawrence C. Kuo, Youwei Yan, Joseph J. Lynch, (unknown)	9
8	Lack of Protection with a Novel, Selective Melanocortin Receptor Subtype-4 Agonist RY767 in a Rat Transient Middle Cerebral Artery Occlusion Stroke Model 2008 ·Pharmacology ·Christopher P. Regan, (unknown), Alison M. Strack, David H. Weinberg, Ravi P. Nargund, Zhixiong Ye, (unknown), Tung M. Fong, Ian J. Reynolds, Joseph J. Lynch	9
9	Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor 2008 ·Neuroscience Research ·Kelley A. Foster, (unknown), Andrew Danziger, (unknown), Nancy Kwon, Keith Rickert, Joseph J. Lynch, Christopher P. Regan	11
10	Cyclic benzamidines as orally efficacious NR2B-selective NMDA receptor antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Kevin T. Nguyen, Christopher F. Claiborne, John A. McCauley, Brian E. Libby, David A. Claremon, Rodney A. Bednar, Scott D. Mosser, Stanley L. Gaul, Thomas Connolly, Cindra Condra, Bohumil Bednář, Gary L. Stump, Joseph J. Lynch, Kenneth S. Koblan, Nigel J. Liverton	19
11	Pharmacological Modulation of IKs: Potential for Antiarrhythmic Therapy 2004 ·Current Medicinal Chemistry ·Joseph J. Salata, Harold G. Selnick, Joseph J. Lynch	19
12	Azaindoles: moderately basic P1 groups for enhancing the selectivity of thrombin inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Philip E.J. Sanderson, Matthew G. Stanton, Bruce D. Dorsey, Terry A. Lyle, Colleen M. McDonough, William M. Sanders, (unknown), Adel M. Naylor-Olsen, Julie A. Krueger, Sidney D. Lewis, Bobby J. Lucas, Joseph J. Lynch, Youwei Yan	21
13	Theodicy and Animals 2002 ·Between the Species An Online Journal for the Study of Philosophy and Animals ·Joseph J. Lynch	1
14	EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction 1999 ·Journal of the American College of Cardiology ·Joseph J. Lynch, Gary L. Stump, Audrey A. Wallace, (unknown), (unknown), (unknown), R J Gould, William Grossman	12
15	Non-Peptide Fibrinogen Receptor Antagonists. 2. Optimization of a Tyrosine Template as a Mimic for Arg-Gly-Asp 1994 ·Journal of Medicinal Chemistry ·Melissa S. Egbertson, (unknown), (unknown), R J Gould, Wasyl Halczenko, George D. Hartman, William L. Laswell, Joseph J. Lynch, Robert J. Lynch	147
16	Hypothyroidism Renders Protection Against Lethal Ventricular Arrhythmias in a Conscious Canine Model of Sudden Death 1991 ·Journal of Cardiovascular Pharmacology ·Nagammal Venkatesh, Joseph J. Lynch, Andrew C. G. Uprichard, Jan M. Kitzen, Bramah N. Singh, Benedict R. Lucchesi	16
17	Endothelial Barrier Function. 1989 ·Journal of Investigative Dermatology ·Asrar B. Malik, Joseph J. Lynch, Jeffrey A. Cooper	26
18	Increase in experimental infarct size with digoxin in a canine model of myocardial ischemia-reperfusion injury 1988 ·American Heart Journal ·Joseph J. Lynch, Paul J. Simpson, Kim P. Gallagher, Thomas B. McClanahan, (unknown), (unknown)	9
19	Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: Evaluation in a conscious canine model of sudden death 1987 ·Journal of the American College of Cardiology ·William H. Kou, Steven D. Nelson, Joseph J. Lynch, Daniel Montgomery, Lorenzo A. DiCarlo, Benedict R. Lucchesi	43
20	Effects of Flecainide Acetate on Ventricular Tachyarrhythmia and Fibrillation in Dogs with Recent Myocardial Infarction 1987 ·Pharmacology ·Joseph J. Lynch, Lorenzo A. DiCarlo, Daniel Montgomery, Benedict R. Lucchesi	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact